Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qubist Molecular Design
Parkville, Victoria, Australia
- Ownership
- Private
- Development stage
- Other
01
Overview
Qubist Molecular Design was an Australian biotechnology company specializing in computational drug design and molecular modeling. Founded in 2009 by Professor Andrew Wilks and colleagues, the company utilized quantum chemistry and advanced optimization algorithms to support the discovery of novel small molecule therapeutics. Notably, the company's modeling expertise contributed to the development of momelotinib (Ojjaara), a JAK inhibitor approved for myelofibrosis. In 2024, Qubist Molecular Design merged with Presagen to form Qubigen, an AI-driven drug discovery firm that combines federated AI with quantum chemistry.
- Therapeutic areas
- ImmunologyHematologyOncology
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
CytopiaSYN|thesis Med ChemMonash Institute of Pharmaceutical SciencesBioproton
Beyond the preview
Go deeper on Qubist Molecular Design.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qubist Molecular Design.